Actively Recruiting
The LungVision Navigational Platform for Preoperative Labeling of Pulmonary Ground Glass Nodules With Fiducial Markers
Led by IRCCS Azienda Ospedaliero-Universitaria di Bologna · Updated on 2025-09-18
5
Participants Needed
1
Research Sites
31 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Based on current evidence, there are no studies investigating the possibility of placing a fiducial marker using augmented fluoroscopy, particularly for partially solid lesions that are often not visible on traditional fluoroscopy. The study in question could provide evidence that will allow, in the future, the use of the LungVision system and radial ultrasound to effectively mark a lesion with a ground glass component highly suspected of malignancy via bronchoscopy, avoiding more invasive marking procedures such as trans-thoracic marking. Correct marking of the target lesion will allow easy identification of the lesion during surgery and its complete removal through small resections, obtaining a definitive histological diagnosis and, in some cases, radical oncological treatment with preservation of healthy lung tissue.
CONDITIONS
Official Title
The LungVision Navigational Platform for Preoperative Labeling of Pulmonary Ground Glass Nodules With Fiducial Markers
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Presence of a partially solid peripheral lung nodule with a solid component 6 mm or larger, or a growing nodule, seen on chest CT
- Nodule has a bronchus sign or is adjacent to a bronchus on chest CT
- Patient provides informed consent to participate
You will not qualify if you...
- Pregnancy or suspected pregnancy
- Contraindication to bronchoscopy under deep sedation, as assessed by anesthesiologist
- High surgical risk making patient ineligible for surgery, as assessed by anesthesiologist
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Bologna, Bologna, Italy, 40138
Actively Recruiting
Research Team
P
Piero Candoli, MD
CONTACT
G
Gian Piero Bandelli, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here